 Nes-Ziona, Israel, June 07, 2022 GLOBE NEWSWIRE -- Enlivex Therapeutics Ltd. Nasdaq: ENLV, a clinical-stage macrophage reprogramming immunotherapy company targeting diseased macrophages in patients with sepsis and solid tumors, today announced that company management will present a corporate update at the 2022 Jefferies Healthcare Conference, which is taking place at the Marriott Marquis in New York, NY. The presentation will take place on June 9, 2022, at 1:00 PM Eastern Time. A webcast of the presentation will be available at , and will be archived for 90 days. 